CRYOFOCUS-B's frozen probe registration change approved by the National Medical Products Administration
CRYOFOCUS-B (06922.HK) announced that the registration of the disposable cryoprobes for the group's frozen adhesion treatment system has been changed to reflect that the cryoprobes have received approval from the National Medical Products Administration. After obtaining the approval, the commercialization path for the group's frozen adhesion treatment system will be further improved, and the cryoprobes will comprehensively cover relevant indications with both disposable and reusable product characteristics
Source: AASTOCKS The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments